Crossmark

Potentialities of Cashew Nut (Anacardium occidentale) By-Product for Pharmaceutical Applications: Extraction and Purification Technologies, Safety, and Anti-inflammatory and Anti-arthritis Activities

Crossref DOI link: https://doi.org/10.1007/s43450-020-00090-w

Published Online: 2020-09-22

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

dos Santos, Ariane Teixeira https://orcid.org/0000-0002-6465-1107
Guerra, Gerlane Coelho Bernardo https://orcid.org/0000-0002-2556-8116
Marques, José Ivan https://orcid.org/0000-0002-6373-3012
Torres-Rêgo, Manoela https://orcid.org/0000-0002-8535-1533
Alves, Jovelina Samara Ferreira https://orcid.org/0000-0003-3445-8733
Vasconcelos, Roseane Carvalho https://orcid.org/0000-0001-9208-4464
de Souza Araújo, Daline Fernandes https://orcid.org/0000-0003-3605-7247
Abreu, Lucas Silva https://orcid.org/0000-0001-5620-8095
de Carvalho, Thaís Gomes https://orcid.org/0000-0002-1317-8890
de Araújo, Daniel Rodrigo Cavalcante https://orcid.org/0000-0001-5622-6859
Tavares, Josean Fechine https://orcid.org/0000-0003-0293-2605
de Araújo, Aurigena Antunes https://orcid.org/0000-0001-9264-4695
de Araújo Júnior, Raimundo Fernandes https://orcid.org/0000-0003-2349-2354
de Freitas Fernandes-Pedrosa, Matheus https://orcid.org/0000-0003-4221-9580
de Santis Ferreira, Leandro https://orcid.org/0000-0002-8408-5886
Zucolotto, Silvana Maria https://orcid.org/0000-0002-2768-0793
Funding

Funding for this research was provided by:

CAPES (Finance Code 001)

CNPQ (478661/2010-0)
License Information

Text and Data Mining valid from 2020-09-22

Version of Record valid from 2020-09-22
More Information

Article History

Received: 14 June 2020

Accepted: 24 August 2020

First Online: 22 September 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below